Uncategorized
Eylea (aflibercept) for AMD gets EU agency backing
LONDON (Reuters) - EU drugs regulators have recommended Regeneron's and Bayer's eye drug Eylea
(aflibercept) for approval in a move likely to see the new medicine eat away further at rival Roche's market
share.